Events
In case you missed it, check out the recordings from our two recent webinars:
News
- Janice Chang Named New CEO of TransCelerate and BioCelerate.
- BioCelerate Newsletter – November 2021
- Harmonization of SEND Implementation to Enable Historical Control Data Analysis, the Recommendations for Populating Control Type (TCNTRL) with CDISC SEND Controlled Terminology White Paper was published on the PHUSE website.
- BioCelerate Continues to Help Improve Nonclinical Study Operations through Public Private Partnership with the FDA
- BioCelerate Newsletter – April 2021
- SEND Implementation for Cross-Study Analysis Initiative Publishes New Manuscript: Leveraging the Value of CDISC SEND Datasets for Cross-Study Analysis: Incidence of Microscopic Findings in Control Animals
- BioCelerate Newsletter – November 2020
- BioCelerate Newsletter – June 2020
- BioCelerate Newsletter – March 2020
- BioCelerate Releases new SEND Paper
- BioCelerate Featured in Applied Clinical Trials
- BioCelerate Releases v1.0 of the Nonclinical Protocol Template for Repeat-Dose Toxicology Studies
- BioCelerate Newsletter – November 2019
- BioCelerate Newsletter – July 2019
- BioCelerate Launches Two New Initiatives and Expands Membership
- BioCelerate Newsletter – April 2019
- TransCelerate and BioCelerate Launch New Technology Platform to Enable R&D Data Sharing
- TransCelerate BioPharma Introduces New Subsidiary BioCelerate to Increase Efficiencies in Preclinical Research
- TransCelerate Biopharma Targets Preclinical Research with BioCelerate